-
ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced the introduction of a new, narrower size of AQUACEL® and AQUACEL® Ag Ribbon Dressings with Strengthening Fibers, now available in the U.S. and select European countries for the management of moderate to highly exuding ...
-
Millions of Americans struggling with psoriasis and psoriatic arthritis are one step closer to a cure with the first-ever release of National Psoriasis Victor Henschel BioBank DNA samples for use in psoriasis research. The samples will allow scientists to uncover the unknowns about the genetics of psoriatic disease and its ...
-
Bed bugs appear to be on the rise around the world, as more and more experts and professionals in pest control report huge rises in prevalence, even so far as to suggest we are on the verge of a bed bug pandemic......
-
A NEW survey released today (Wednesday 1 September) reveals almost half of Brits (46 per cent) got sunburnt this year. Of those who got burnt, a third (32 per cent) admitted their motivation was to get a tan. And half of those who burnt whilst trying to get a tan ...
-
The Norwegian pharmaceutical company Lytix Biopharma AS today announces the approval in Hungary to commence a Phase IIa clinical trial with LytixarTM (LTX-109) treatment of skin infections caused by Gram positive bacteria......
-
Scientists from the National Institutes of Health and University of Chicago have found a promising treatment method that in laboratory mice reduces the severity of skin and soft-tissue damage caused by USA300, the leading cause of community-associated Staphylococcus aureus infections in the United States......
-
An antibacterial peptide developed by Laszlo Otvos, a research professor of biology in Temple's College of Science and Technology, looks to be a highly-effective therapy against infections in burn or blast wounds suffered by soldiers......
-
Medicis (NYSE:MRX) announced that the U.S. Food and Drug Administration (FDA) has approved additional strengths of SOLODYN(R) (minocycline HCl, USP) Extended Release Tablets in 55 mg, 80 mg and 105 mg dosages for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of ...
-
Maybe you worshipped the sun in your youth or weren't as meticulous as you should have been with sunscreen. If so, take heart: Scientists at The University of Texas Health Science Center San Antonio are finding that certain plant substances, when given in combinations, may suppress damage that can cause ...
-
Errors in the copying of genes during cell division can cause numerous diseases, including cancer. Yale School of Medicine scientists, however, have unraveled the secrets of a much more rare phenomenon with potential therapeutic implications - disease-causing genes that show a high frequency of self-repair......
-
By creating diseased liver cells from a small sample of human skin, scientists have for the first time shown that stem cells can be used to model a diverse range of inherited disorders. The University of Cambridge researchers' findings, which will hopefully lead to new treatments for those suffering from ...
-
Cascade Technologies, Inc. (OTCBB: CSDT) announced today that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI) will complete development of its new product SkinSpect™, aimed at early detection of melanoma by hyperspectral imaging, in mid-September 2010, significantly ahead of schedule......
-
Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM) announced that its subsidiary Wound Care Innovations, LLC has further expanded its rapidly growing coverage of the Florida wound care market with the addition of Central Medical Systems to its already extensive list of distributors and suppliers......
-
A drug initially developed to protect skin from light and UV will soon be tested as a repigmentation therapy in vitiligo, a common disorder which causes skin to gradually lose its pigment or tone. SCENESSE(R), a new drug developed in Australia, will be evaluated for its ability to reactivate melanin ...
-
The U.S. Food and Drug Administration is warning consumers about the risk of ultraviolet radiation overdose with the Tootsie Tanner portable foot tanning device. Use of the tanning device can lead to an overdose of ultraviolet radiation because its labeling recommends an improper duration of exposure to radiation and the ...
-
Jordan Hospital is pleased to announce that it has received approval from the Massachusetts Department of Public Health for the opening of its new, state-of-the-art Wound Healing and Hyperbaric Center (Wound Center) located on the hospital campus in Plymouth, Mass. The Wound Center features the only hospital-based hyperbaric treatment chamber ...
-
Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and its Prelude™ SkinPrep System for transdermal drug delivery, announced the completion of a clinical study of Prelude......
-
The Melanoma Research Alliance ("MRA") today announced $5.2 million in grants to support six multidisciplinary teams pursuing innovative, translational research approaches designed to benefit melanoma patients......
-
Patients who receive a diagnosis of the skin cancer basal cell carcinoma at a younger age-along with those who have red hair, a higher socioeconomic status and a cancerous lesion on their upper extremities-appear to be at higher risk of developing multiple cancers and require closer follow-up, according to a ...
Dermatology